Latest Press Releases

Weight Watchers Launches a Fully Integrated Platform for the GLP-1 Era

NEW YORK, Dec. 16, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers”), the global leader in science-backed weight management, today introduced a new, fully integrated experience bringing together comprehensive ...

Saudi Arabia’s Quality of Life Program Highlights Pathways to Transformative Progress in Lifestyle in New Report and Global Index Initiative

The “ Cities of Possibility: The Evolution of Quality of Life in Saudi Arabia” report reveals how a focus on quality of life has enhanced citizen well-being. From lifestyle and recreation to opportunity and social growth, measurements from ...

Building Clinical Judgment: How Nursing Students Learn to Think Like Nurses

Nursing students are not only learning procedures and protocols; they are actively developing the ability to notice subtle changes, prioritize under pressure, and choose the safest next step for each patient. Clinical judgment is what gradually ...

The Role of Nursing Assignment Writing Services in Today's Healthcare Education

Nursing education continues to evolve rapidly as healthcare systems worldwide grow more complex and technologically advanced. From clinical reasoning to evidence-based practice and patient-centered care, nursing students are expected to master a ...

Philips Agrees to Acquire SpectraWAVE Inc., Advancing Next-generation Coronary Intravascular Imaging and Physiological assessment with AI

December 15, 2025 Acquisition of SpectraWAVE’s next-generation technologies including HyperVue TM Imaging System with Enhanced Vascular Imaging for comprehensive, rapid, and AI-supported imaging inside the coronary arteries, and X1 TM -FFR, ...

Byron Medical Announces the Product Release of BlancOne: A Science-Powered Breakthrough Redefining In-Chair Whitening Technology

BRISBANE, Australia, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Byron Medical is excited to announce their exclusive distribution of BlancOne, a system developed with cutting-edge photochemistry and biophotonics that is rewriting the rules of ...

Io Therapeutics, Inc., presents today at the San Antonio Breast Cancer Symposium preclinical studies demonstrating effectiveness of IRX4204, the company’s clinical stage retinoid X nuclear receptor (RXR) agonist compound, for synergistically promoting killing of HER2+ breast cancer cells in combination with HER2-targeted chimeric antigen receptor modified T-cells (CAR-T).

SPRING, Texas, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Io Therapeutics, Inc., a privately held pharmaceutical company headquartered in Spring, Texas; announced today presentation at the San Antonio Breast Cancer Symposium, in San Antonio, TX; of data ...

Avance Clinical Launches Diversity in STEM Scholarships Across Australia and North America

ADELAIDE, Australia, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Avance Clinical, the award-winning global CRO for biotechs, has announced the launch of its new Diversity in STEM Scholarships , a global initiative designed to support women and ...

New Modeling Approach Sheds Light on Rare Gut Disease

PR Newswire NEW YORK, Dec. 16, 2025 NEW YORK, Dec. 16, 2025 /PRNewswire/ -- During development of the digestive system, a complex network of nerves forms around it, creating a "second brain" — the enteric nervous system (ENS) — which ...

Breakthrough Progress: METiS TechBio Publishes Consecutive Research Findings in Nature Communications and the Journal for ImmunoTherapy of Cancer

PR Newswire BEIJING, Dec. 16, 2025 BEIJING, Dec. 16, 2025 /PRNewswire/ -- METiS TechBio ("METiS") today announced that two of its oncology pipeline candidates, MTS-105 and MTS-107, have been published in leading international peer-reviewed ...

General Medicine Launches AI That Connects Feeling Heard to Getting Care

PR Newswire SAN FRANCISCO, Dec. 16, 2025 People are turning to AI for health questions. General Medicine is making those conversations productive by connecting them to doctors who can help. SAN FRANCISCO, Dec. 16, 2025 /PRNewswire/ ...

Kick the Nic in 2026: American Lung Association Offers Support to Help People Quit All Nicotine and Tobacco Products for Good

PR Newswire CHICAGO, Dec. 16, 2025 The American Lung Association encourages people who use tobacco and nicotine products to make a resolution to quit in 2026, provides free resources CHICAGO, Dec. 16, 2025 /PRNewswire/ -- Currently, ...

Building Clinical Judgment: How Nursing Students Learn to Think Like Nurses

Nursing students are not only learning procedures and protocols; they are actively developing the ability to notice subtle changes, prioritize under pressure, and choose the safest next step for each patient. Clinical judgment is what gradually ...

The Role of Nursing Assignment Writing Services in Today's Healthcare Education

Nursing education continues to evolve rapidly as healthcare systems worldwide grow more complex and technologically advanced. From clinical reasoning to evidence-based practice and patient-centered care, nursing students are expected to master a ...

Breaking the "Untreatable": Biostar Pharma's UTD1 Achieves First Patient Dosing in U.S. for Pivotal Clinical Trial for Breast Cancer Brain Metastases

PR Newswire SAN FRANCISCO, Dec. 15, 2025 SAN FRANCISCO, Dec. 15, 2025 /PRNewswire/ -- Biostar Pharma, Inc., the U.S. wholly-owned subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd. (Stock Code: 2563.HK), today announced that the first ...

Nektar to Hold Conference Call to Discuss Topline Results from the 36-Week Induction Treatment Period for its REZOLVE-AA Phase 2b Study of Rezpegaldesleukin in Alopecia Areata on December 16, 2025

PR Newswire SAN FRANCISCO, Dec. 15, 2025 SAN FRANCISCO, Dec. 15, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR), a clinical-stage biotechnology company focused on development of novel immunology therapies, today announced it will ...

Gene Therapies for Cardiomyopathies Market Poised for Rapid Expansion During the Forecast Period (2025-2034) with Advancements in AAV and CRISPR Platforms | DelveInsight

PR Newswire LAS VEGAS, Dec. 15, 2025 The gene therapies for cardiomyopathies market is poised for strong growth as advancements in genomic medicine accelerate the development of targeted treatments for inherited and acquired cardiac ...

ADEL Signs $1.04 Billion Global License Agreement with Sanofi for ADEL-Y01, a Novel investigational Alzheimer's Disease Therapy

PR Newswire SEOUL, South Korea, Dec. 15, 2025 SEOUL, South Korea, Dec. 15, 2025 /PRNewswire/ -- ADEL, Inc., a biopharmaceutical company dedicated to developing therapies for neurodegenerative diseases such as Alzheimer's Disease, today ...

MedStar Health Acquires Hope for Henry Foundation Ensuring Quality of Life Program Continues Helping Children Undergoing Medical Treatment

PR Newswire COLUMBIA, Md., Dec. 15, 2025 COLUMBIA, Md., Dec. 15, 2025 /PRNewswire/ -- MedStar Health announces the acquisition of the Hope for Henry Foundation, a nationally recognized nonprofit transforming pediatric care. Hope for Henry's ...

AZmed Expands Into CT Imaging With CE-Marked AZnod, An AI Tool for Lung Nodule Detection and the First Product in the Rayscan® Line

PR Newswire PARIS, Dec. 15, 2025 PARIS, Dec. 15, 2025 /PRNewswire/ -- AZmed, one of the leading companies in artificial intelligence (AI) for radiology, announced today the CE marking of AZnod, its first AI tool for computed tomography (CT) ...

Roche receives FDA approval for first diagnostic tests to identify HER2-positive metastatic breast cancer patients eligible for ENHERTU

PR Newswire TUCSON, Ariz., Dec. 15, 2025 TUCSON, Ariz., Dec. 15, 2025 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved additional indications for its PATHWAY ...

Healthcare IT Market Set to More Than Double by 2030 Growing at 15.24% CAGR, Reports Mordor Intelligence

PR Newswire HYDERABAD, India, December 15, 2025 HYDERABAD, India, December 15, 2025 /PRNewswire/ -- According to Mordor Intelligence, the healthcare IT market is valued at USD 413.14 billion in 2025, and is projected to surpass USD 839.67 ...

Breast Pump Market Set to Grow at an Impressive CAGR of 8.75% Through 2035 | 8.12 USD Billion | Vantage Market Research

PR Newswire NEW YORK, Dec. 15, 2025 NEW YORK, Dec. 15, 2025 /PRNewswire/ -- The Global Breast Pump Market is entering a transformational decade shaped by rising maternal health prioritization, remote lactation support ecosystems, and ...

Minghui Pharmaceutical Announces FDA clearance of IND to Initiate Global Phase ? Trials of MHB018A, a Subcutaneous Single-Domain IGF-1R Antibody, in Thyroid Eye Disease

PR Newswire SHANGHAI and HANGZHOU, China, Dec. 15, 2025 SHANGHAI and HANGZHOU, China, Dec. 15, 2025 /PRNewswire/ -- Minghui Pharmaceutical, a late-stage biopharmaceutical company dedicated to developing transformative medicines in immunology ...

Ascletis Announces Positive Topline Results from U.S. Phase I Study of ASC50, a Potential Best-in-Class Oral Small Molecule IL-17 Inhibitor

PR Newswire HONG KONG, Dec. 15, 2025 - The elimination half-life of ASC50 after a single oral dose was 43, 89, 91, 87, 104, and 85 hours for 10 mg, 30 mg, 100 mg, 200 mg, 400 mg, and 600 mg, respectively, supporting once-daily or ...

Brayton Purcell LLP Highlights Massachusetts Safety Alert After State's First Silicosis Case in Artificial Stone Industry

PR Newswire Novato, Calif., Dec. 13, 2025 Law firm urges awareness as state confirms first case linked to artificial stone countertops fabrication; nationwide surge signals urgent public health concern. Novato, Calif., Dec. 13, 2025 ...

Sobi to acquire Arthrosi Therapeutics, strengthening pipeline for the potential treatment of gout

PR Newswire STOCKHOLM, Dec. 13, 2025 STOCKHOLM, Dec. 13, 2025 /PRNewswire/ -- Sobi® (STO: SOBI) has entered into a definitive agreement to acquire Arthrosi Therapeutics, Inc. (Arthrosi), a private late-stage biotechnology company focused on ...

U.S. FDA approves AKEEGA® as the first precision therapy for BRCA2-mutated metastatic castration-sensitive prostate cancer with 54% reduction in disease progression vs standard of care*

PR Newswire HORSHAM, Pa., Dec. 12, 2025 Expanded indication for AKEEGA® (niraparib and abiraterone acetate dual-action tablet) plus prednisone marks the first FDA-approved precision medicine combination treatment for patients with ...

Hormone Replacement Therapy - FDA Removes Black Box Warning - Kass Precision Medicine

PR Newswire SEATTLE, Dec. 12, 2025 For more than 20 years, a black box warning and poor education created fear in both patients and clinicians. An entire generation of women suffered unnecessarily and were denied essential care that impacted ...

Updated data for Lilly's Inluriyo™ (imlunestrant) reinforce efficacy results as monotherapy and in combination with Verzenio® (abemaciclib) in ER+, HER2- advanced breast cancer

PR Newswire INDIANAPOLIS, Dec. 12, 2025 As monotherapy, imlunestrant demonstrated an 11.4-month numeric improvement in median OS versus endocrine therapy in patients with ESR1-mutated disease In all patients, the imlunestrant plus ...

Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance

PR Newswire VANCOUVER, BC, Dec. 12, 2025 Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Dec. 12, 2025 /PRNewswire/ -- USANewsGroup.com News Commentary – Scientists developed an antibody treatment that reawakens the immune ...

AI Diagnostics Hit Critical Mass as Hospitals Race to Cut Costs

PR Newswire VANCOUVER, BC, Dec. 12, 2025 ISSUED ON BEHALF OF VENTRIPOINT DIAGNOSTICS LTD. VANCOUVER, BC, Dec. 12, 2025 /PRNewswire/ -- USANewsGroup.com News Commentary – Point-of-care infectious disease diagnostics valued at $53 billion ...

Boston Public Schools Ensures Every Student, Family, and Staff Member Has Mental Health Care

PR Newswire BOSTON, Dec. 12, 2025 New landmark partnership with Cartwheel, The Brookline Center for Community Mental Health (BCCMH), and Boston Public Schools ensures timely, multilingual mental health services for students, families, ...

Actinium Pharmaceuticals Presents New Preclinical Data Demonstrating Potent Anti-Tumor Activity of ATNM-400 Across Multiple Breast Cancer Subtypes Including Hormone Receptor-Positive, Triple-Negative, and Tamoxifen- and HER2 Therapy-Resistant Breast Cancer Models at SABCS 2025

PR Newswire NEW YORK, Dec. 12, 2025 - ATNM-400's target antigen is overexpressed in breast cancer and its expression is further increased in breast cancer cells resistant to standard of care endocrine therapy, tamoxifen and the HER2 ...

Ractigen Therapeutics Doses First Patient in IIT Study of RAG-18, a Potential Game-Changing saRNA Therapeutic for Duchenne Muscular Dystrophy

PR Newswire NANTONG, China, Dec. 12, 2025 NANTONG, China, Dec. 12, 2025 /PRNewswire/ -- Ractigen Therapeutics, a pioneering developer of small activating RNA (saRNA) therapeutics, today announced the successful dosing of the first patient in ...

Flu Season Predicted to Be "Nasty This Winter." IQ AIR Can Help

PR Newswire FORT LAUDERDALE, Fla., Dec. 12, 2025 LifeBridge's Lung Immunity Support Is a Tool for Respiratory Health During a Busy Holiday Season FORT LAUDERDALE, Fla., Dec. 12, 2025 /PRNewswire/ -- New report finds the flu season could ...

Ractigen Therapeutics Doses First Patient in IIT Study of RAG-18 for Duchenne Muscular Dystrophy

PR Newswire NANTONG, China, Dec. 12, 2025 NANTONG, China, Dec. 12, 2025 /PRNewswire/ -- Ractigen Therapeutics, a pioneering developer of small activating RNA (saRNA) therapeutics, today announced the successful dosing of the first patient in ...

Peijia Medical Receives NMPA Approval for TaurusTrio Transcatheter Aortic Valve System, Pioneering Treatment for Aortic Regurgitation in China

PR Newswire HONG KONG, Dec. 12, 2025 HONG KONG, Dec. 12, 2025 /PRNewswire/ -- Peijia Medical (9996.HK), a leading Chinese domestic company in the high-growth transcatheter valve therapeutics and neurovascular interventions markets, announced ...

MEDINDIA

Search Medindia

Latest Press Releases

Premium Press Releases »

Press Releases »

Latest Press Releases